SENESCORE Trademark

Trademark Overview


On Tuesday, July 9, 2024, a trademark application was filed for SENESCORE with the United States Patent and Trademark Office. The USPTO has given the SENESCORE trademark a serial number of 98638764. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Saturday, February 1, 2025. This trademark is owned by Ponce Therapeutics, Inc.. The SENESCORE trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Biologic age scoring; Statistical scoring to determine a biologic age score of a patient; Anti-aging therapy; Anti-aging services; Medical services; Medical services, namely, anti-aging services; Medical services, namely, prevention and treatment of age-related disorders; Medical research services; Medical research services, namely, anti-aging services; Medical research services, namely, prevention and treatment of age-related disorders; Medical advisory services; Medical advisory services, namely, anti-aging services; Medical advisory services, namely, prevention and treatment of age-related disorders; Medical testing services; Medical testing services, namely, anti-aging services; Medical testing services, namely, prevention and treatment of age-related disorders; Medical services in the field of anti-aging; Medical services in the field of senescent cells; Medical services in the field of age-related disorders; Biopsy services; Biopsy services related to biologic age; Biopsy service...
senescore

General Information


Serial Number98638764
Word MarkSENESCORE
Filing DateTuesday, July 9, 2024
Status638 - NEW APPLICATION - ASSIGNED TO EXAMINER
Status DateSaturday, February 1, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkSENES CORE
Goods and ServicesBiologic age scoring; Statistical scoring to determine a biologic age score of a patient; Anti-aging therapy; Anti-aging services; Medical services; Medical services, namely, anti-aging services; Medical services, namely, prevention and treatment of age-related disorders; Medical research services; Medical research services, namely, anti-aging services; Medical research services, namely, prevention and treatment of age-related disorders; Medical advisory services; Medical advisory services, namely, anti-aging services; Medical advisory services, namely, prevention and treatment of age-related disorders; Medical testing services; Medical testing services, namely, anti-aging services; Medical testing services, namely, prevention and treatment of age-related disorders; Medical services in the field of anti-aging; Medical services in the field of senescent cells; Medical services in the field of age-related disorders; Biopsy services; Biopsy services related to biologic age; Biopsy services related to biological age scoring; Biopsy services related to determining a number or percentage of senescent cells; Laboratory services; Laboratory services related to biologic age; Laboratory services related to biological age scoring; Laboratory services related to determining a number or percentage of senescent cells; Non-invasive testing; Non-invasive testing related to biologic age; Non-invasive testing related to biological age scoring; Non-invasive testing related to determining a number or percentage of senescent cells

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, July 9, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePonce Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSurfside, FL 33154

Trademark Events


Event DateEvent Description
Tuesday, July 9, 2024NEW APPLICATION ENTERED
Saturday, February 1, 2025ASSIGNED TO EXAMINER
Friday, January 31, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED